Prostaglandin endoperoxide analogues stimulate formation of 1,2-diacylglycerol and myo-inositol 1,4,5-triphosphate in human platelets.
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D004075:Diglycerides / Q000096:biosynthesis / Q000097:blood*; D005989:Glycerides / Q000097:blood*; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D015544:Inositol 1,4,5-Trisphosphate; D007295:Inositol Phosphates / Q000096:biosynthesis / Q000097:blood*; D007700:Kinetics; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology*; D013403:Sugar Phosphates / Q000097:blood*
D004075:Diglycerides; D005989:Glycerides; D007295:Inositol Phosphates; D011450:Prostaglandin Endoperoxides, Synthetic; D013403:Sugar Phosphates; C028429:U 44069; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D015544:Inositol 1,4,5-Trisphosphate; D007213:Indomethacin